Human T-Lymphotropic virus type II seroprevalence among emergency department and clinic patients

Western Journal of Medicine

Volumn 164, Issue 6, 1996, Pages 481-485

  Agranoff, Daniel ^a,b   Varney, Karen ^a   Khayam Bashi, Hassan ^a   Murphy, Edward L ^a,c  

^a SAN FRANCISCO GENERAL HOSPITAL   (United States)

^b ST GEORGE S HOSPITAL   (United Kingdom)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; DRUG ABUSE; DRUG USE; EMERGENCY WARD; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN T CELL LEUKEMIA VIRUS 2; HUMAN T CELL LEUKEMIA VIRUS INFECTION; IMMUNOBLOTTING; MAJOR CLINICAL STUDY; MALE; OCCUPATIONAL HAZARD; PREVALENCE; SERODIAGNOSIS; SPINAL CORD DISEASE; UNITED STATES;

ADULT; AGED; AMBULATORY CARE FACILITIES; BLOTTING, WESTERN; CALIFORNIA; EMERGENCY SERVICE, HOSPITAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HTLV-I ANTIBODIES; HTLV-I INFECTIONS; HTLV-II ANTIBODIES; HTLV-II INFECTIONS; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; PREVALENCE; RISK FACTORS; SEROEPIDEMIOLOGIC STUDIES; SEX DISTRIBUTION;

EID: 0029892867     PISSN: 00930415     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Poiesz BJ, Ruscetti FW, Gazdar AF, Bunn PA, Minna JD, Gallo RC: Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma. Proc Natl Acad Sci USA 1980; 77:7415-7419
2. Hinuma Y, Nagata K, Hanaoka M, et al: Adult T-cell leukemia: Antigen in an ATL cell line and detection of antibodies to the antigen in human sera. Proc Natl Acad Sci USA 1981; 78:6476-6480
3. Murphy EL, Blattner WA: HTLV-I-associated leukaemia: A model for chronic retroviral diseases. Ann Neurol 1988; 23:S174-S180
4. Gessain A, Barin F, Vernant JC, et al: Antibodies to human T-lymphotropic virus type-I in patients with tropical spastic paraparesis. Lancet 1985; 2:407-410
5. Hjelle B, Appenzeller O, Mills R, et al: Chronic neurodegenerative disease associated with HTLV-II infection. Lancet 1992; 339:645-646
6. Murphy EL, Engstrom JW, Miller K, Sacher RA, Busch MP, Hollingsworth CG, and the REDS Investigators: HTLV-II associated myelopathy in 43-year-old woman (Letter). Lancet 1993; 341:757-758
7. Jacobson S, Lehky T, Nishimura M, Robinson S, McFarlin DE, Dhib-Jalbut S: Isolation of HTLV-II from a patient with chronic, progressive neurological disease clinically indistinguishable from HTLV-I-associated myelopathy/tropical spastic paraparesis. Ann Neurol 1993; 33:392-396
8. Williams AE, Fang CT, Slamon DJ, et al: Seroprevalence and epidemiological correlates of HTLV-I infection in US blood donors. Science 1988; 240: 643-646
9. Lee HH, Swanson P, Rosenblatt JD, et al: Relative prevalence and risk factors of HTLV-I and HTLV-II infection in US blood donors. Lancet 1991; 337:1435-1439
10. Eble BE, Busch MP, Guiltinan AM, Khayam-Bashi H, Murphy EL: Determination of human T lymphotropic virus type by polymerase chain reaction and correlation with risk factors in northern California blood donors. J Infect Dis 1993; 167:954-957 [erratum published in J Infect Dis 1993; 168:262]
11. Robert-Guroff M, Weiss SH, Giron JA, et al: Prevalence of antibodies to HTLV-I, -II, and -III in intravenous drug abusers from an AIDS endemic region. JAMA 1986; 255:3133-3137
12. Ehrlich GD, Glaser JB, La Vigne K, et al: Prevalence of human T-cell leukaemia/lymphoma virus (HTLV) type II infection among high risk individuals: Type-specific identification of HTLVs by polymerase chain reaction. Blood 1989; 74:1658-1664
13. Lee H, Swanson P, Shorty VS, Zack JA, Rosenblatt JD, Chen ISY: High rate of HTLV-II infection in seropositive IV drug abusers in New Orleans. Science 1989; 244:471-475
14. Hjelle B, Ray M, Swenson S, Mertz G, Key C, Allen S: Incidence of hairy cell leukaemia, mycosis fungoides, and chronic lymphocytic leukaemia in first known HTLV-II-endemic population. J Infect Dis 1991; 163:435-440
15. Lairmore MD, Jacobson S, Gracia F, et al: Isolation of human T-cell lymphotropic virus type 2 from Guaymi Indians in Panama. Proc Natl Acad Sci USA 1990; 87:8840-8844
16. Maloney EM, Biggar RJ, Neel JV. et al: Endemic human T-cell lymphotropic virus type II infection among isolated Brazilian Amerindians. J Infect Dis 1992; 166:100-107
17. Levine PH, Jacobson S, Elliott R, et al: HTLV-II infection in Florida Indians. AIDS Res Hum Retroviruses 1993; 9:123-127
18. Lewandowski C, Ognjan A, Rivers E, et al: Health care worker exposure to HIV-I and HTLV-I/II in critically ill, resuscitated emergency department patients. Ann Emerg Med 1992; 21:1353-1359
19. Kelen GD, DiGiovanna TA, Lofy L, et al: Human T-lymphotropic virus (HTLV I-II) infection among patients in an inner-city emergency department. Ann Intern Med 1990; 113:368-372
20. Rhee KJ, Albertson TE, Kizer KW, Burns MJ, Hughes MJ, Ascher MS: A comparison of HIV-1, HBV and HTLV-I/II seroprevalence rates of injured patients admitted through California emergency departments. Ann Emerg Med 1992; 21:397-401
21. Lipka JJ, Parker JL, Foung SKH: Enhancing the sensitivity of HTLV-I immunoassays, In Blattner WA (Ed): Human Retrovirology: HTLV. New York, NY, Raven Press, 1990, pp 409-417
22. Kleinman SH, Kaplan JE, Khabbaz RF, Calabro MA, Thomson R, Busch M, and the Retrovirus Epidemiology Donor Study Group: Evaluation of a p21e-spiked western blot (immunoblot) in confirming human T-cell lymphotropic virus type I or II infection in volunteer blood donors. J Clin Microbiol 1994; 32:603-607
23. Wiktor SZ, Alexander SS, Shaw GM, et al: Distinguishing between HTLV-I and HTLV-II by western blot (Letter). Lancet 1990; 335:1533
24. Murphy EL, Hanchard B, Figueroa J, et al: Modelling the risk of adult T-cell leukaemia/lymphoma in persons infected with human T-lymphotropic virus type-I. Int J Cancer 1989; 43:250-253
25. Kaplan JE, Osame M, Kubota H, et al: The risk of development of HTLV-I-associated myelopathy/tropical spastic paraparesis among persons infected with HTLV-I. J Acquir Immune Defic Syndr 1990; 3:1096-1101
26. Murphy EL, Fridey J, Smith JW, et al: High prevalence of HTLV-associated myelopathy (HAM) among subjects infected with HTLV-I and HTLV-II (Abstr S-263). Transfusion 1993; 33(9 suppl):68S
27. Feigal E, Murphy EL, Vranizan K, et al: Human T cell lymphotropic virus types I and II in intravenous drug users in San Francisco: Risk factors associated with seropositivity. J Infect Dis 1991; 164:36-42
28. Thiede H, Harris NV, McGough JP, Roberts B, Khabbaz RF, Kaplan JE: Prevalence of HTLV types I and II among drug users in King County, Washington. West J Med 1994; 160:540-544
29. Tosswill JH, Ades AE, Peckham C, Mortimer PP, Weber JN: Infection with human T cell leukaemia/lymphoma virus type I in patients attending an antenatal clinic in London. BMJ 1990; 301:95-96
30. Banatvala JE, Chrystie IL, Palmer SJ, Kenney A: Retrospective study of HIV, hepatitis B, and HTLV-I infection at a London antenatal clinic (Letter). Lancet 1990; 335:859-860
31. Goubau P, Carton H, Cornet P, et al: Human T-cell lymphotropic virus type I infection and tropical spastic paraparesis in Belgian expatriates. J Med Virol 1992; 36:13-15
32. Fahrner R, Gerberding JL: Risk of HIV infection in health care workers, In Volberding PA, Jacobson MA (Eds): AIDS Clinical Review 1993/1994. New York, NY, Marcel Dekker, 1994, pp 239-252